Surgery has long been a standard option in treating mesothelioma, but a new survey from The Mesothelioma Center at Asbestos.com revealed that U.S. surgeons have become more selective about suggesting ...

New research suggests that immunotherapy given before and after surgery could help patients with diffuse pleural mesothelioma, one of the most challenging cancers to treat. A phase II clinical trial ...

The malignant pleural mesothelioma market is poised for steady growth during the forecast period (2025–2034). The launch of innovative therapies by companies such as AstraZeneca, Polaris ...

Malignant mesothelioma is a rare tumor with an annual incidence in the United States of approximately 2500 cases per year. 1 Pleural malignant mesotheliomas are 10–30-fold more common than their ...

Lung cancer and pleural mesothelioma are often confused, so it’s important to understand the key differences between them, including tumor location and treatments. Lung cancer and pleural mesothelioma ...

People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of treatment and the role of ...

The role of surgery for malignant pleural mesothelioma encompasses the need for rapid diagnosis, preoperative staging and surgical resection, and also the need for a greater biological understanding ...

August 31, 2009 — Pleural fluid mesothelin is a helpful adjunct to cytology examination in patients with an undiagnosed pleural effusion, according to the results of a study reported in the September ...

—Malignant pleural mesothelioma is an aggressive tumor that requires a thoughtful approach to staging to identify those most likely to benefit from surgery. Share on Facebook. Opens in a new tab or ...

Nobody likes to talk or think about cancer, but it’s a serious disease that we should all aim to understand a little better. Better understanding the signs and symptoms of cancer, as well as how to ...